| UniProt ID | ZN420_HUMAN | |
|---|---|---|
| UniProt AC | Q8TAQ5 | |
| Protein Name | Zinc finger protein 420 | |
| Gene Name | ZNF420 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 688 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in transcriptional regulation.. | |
| Protein Sequence | MARKLVMFRDVAIDFSQEEWECLDSAQRDLYRDVMLENYSNLVSLDLPSRCASKDLSPEKNTYETELSQWEMSDRLENCDLEESNSRDYLEAKGKMEKQQENQKEYFRQGMIIYDKMSIFNQHTYLSQHSRCHSTEKPYKCKECGKAFRRASHLTQHQSIHTGEKPYECKQCGKAFSRDSQLSLHQRLHTGEKPYACKECGKAFTQSSQLILHHRIHTGEKPYKCEECGKAFIRSSQLTRHQKVHTGEKPYECKECGKAFTQNSQLTLHQRLHTGEKLYECKECRKVFTQLSQLILHKRIHTGEKPYECKECGKAFICGSQLSQHQKIHNGEKPYECKECGRAFIRGSLLMQHQRIHTGEKPYKCEECGKAFIRGSQLTQHQRIHTNEKPYECKECGKMFSHGSQLTQHQRIHTGEKPYQCKECGKAFNRGSLLTRHQRIHTGEKPYECKECGKTFSRGSELTQHERIHTGEKPYECKECGKSFIRGSQLTQHQRIHTGEKPYECKECRMAFTQSSHLSQHQRLHTGEKPYVCNECGKAFARGLLLIQHQRIHTGEKPYQCKECGKAFIRGSQLTQHQRIHTGEKPYECKECGKAFSHGSQLTLHQRIHTGEKPYECRECRKAFTQSSHLSRHQRIHTGEKPYQCKECGKAFTRGSQLTQHQRIHISEKSFEYKECGIDFSHGSQVYM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 39 | Phosphorylation | RDVMLENYSNLVSLD HHHHCCCCCCCEECC | 6.91 | 19835603 | |
| 40 | Phosphorylation | DVMLENYSNLVSLDL HHHCCCCCCCEECCC | 34.96 | 19835603 | |
| 44 | Phosphorylation | ENYSNLVSLDLPSRC CCCCCCEECCCCCHH | 21.23 | 29083192 | |
| 49 | Phosphorylation | LVSLDLPSRCASKDL CEECCCCCHHHCCCC | 47.49 | 29083192 | |
| 68 | Phosphorylation | NTYETELSQWEMSDR CCCHHHHHHHHHHHH | 27.32 | 22817900 | |
| 150 | Ubiquitination | ECGKAFRRASHLTQH HHHHHHHHHHHHHCC | 33.71 | 22505724 | |
| 162 | Phosphorylation | TQHQSIHTGEKPYEC HCCCCCCCCCCCCCC | 45.42 | 29496963 | |
| 170 | Sumoylation | GEKPYECKQCGKAFS CCCCCCCCCCCCCCC | 36.36 | - | |
| 170 | Sumoylation | GEKPYECKQCGKAFS CCCCCCCCCCCCCCC | 36.36 | - | |
| 190 | Phosphorylation | SLHQRLHTGEKPYAC CHHHHHHCCCCCCCH | 52.18 | 21857030 | |
| 198 | Ubiquitination | GEKPYACKECGKAFT CCCCCCHHHHHCCCH | 48.11 | - | |
| 218 | Phosphorylation | ILHHRIHTGEKPYKC HEECCCCCCCCCEEC | 44.67 | 29496963 | |
| 221 | Ubiquitination | HRIHTGEKPYKCEEC CCCCCCCCCEECHHH | 55.80 | - | |
| 223 | Phosphorylation | IHTGEKPYKCEECGK CCCCCCCEECHHHHH | 39.06 | - | |
| 224 | Ubiquitination | HTGEKPYKCEECGKA CCCCCCEECHHHHHH | 43.63 | - | |
| 224 | Sumoylation | HTGEKPYKCEECGKA CCCCCCEECHHHHHH | 43.63 | - | |
| 224 | Sumoylation | HTGEKPYKCEECGKA CCCCCCEECHHHHHH | 43.63 | - | |
| 230 | Ubiquitination | YKCEECGKAFIRSSQ EECHHHHHHHHHHHH | 52.35 | - | |
| 236 | Phosphorylation | GKAFIRSSQLTRHQK HHHHHHHHHCCCCCC | 21.25 | 28348404 | |
| 246 | Phosphorylation | TRHQKVHTGEKPYEC CCCCCCCCCCCCCCC | 50.45 | 21857030 | |
| 249 | Ubiquitination | QKVHTGEKPYECKEC CCCCCCCCCCCCCCC | 55.00 | - | |
| 254 | Sumoylation | GEKPYECKECGKAFT CCCCCCCCCCCCCCC | 44.06 | - | |
| 254 | Sumoylation | GEKPYECKECGKAFT CCCCCCCCCCCCCCC | 44.06 | - | |
| 274 | Phosphorylation | TLHQRLHTGEKLYEC EEEHHHHCCCCCCCC | 52.18 | 21857030 | |
| 290 | Ubiquitination | ECRKVFTQLSQLILH HHHHHHHHHHHHHHH | 27.87 | 22505724 | |
| 298 | Sumoylation | LSQLILHKRIHTGEK HHHHHHHCCCCCCCC | 49.99 | 28112733 | |
| 302 | Phosphorylation | ILHKRIHTGEKPYEC HHHCCCCCCCCCCCC | 44.67 | 29496963 | |
| 310 | Sumoylation | GEKPYECKECGKAFI CCCCCCCCCCCCEEE | 44.06 | - | |
| 310 | Sumoylation | GEKPYECKECGKAFI CCCCCCCCCCCCEEE | 44.06 | - | |
| 358 | Phosphorylation | MQHQRIHTGEKPYKC HHCCCCCCCCCCCCC | 44.67 | 29496963 | |
| 361 | Ubiquitination | QRIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 55.80 | - | |
| 363 | Phosphorylation | IHTGEKPYKCEECGK CCCCCCCCCCHHHCC | 39.06 | - | |
| 364 | Ubiquitination | HTGEKPYKCEECGKA CCCCCCCCCHHHCCE | 43.63 | - | |
| 364 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHCCE | 43.63 | - | |
| 364 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHCCE | 43.63 | - | |
| 370 | Ubiquitination | YKCEECGKAFIRGSQ CCCHHHCCEEECCCC | 52.35 | - | |
| 376 | Phosphorylation | GKAFIRGSQLTQHQR CCEEECCCCCCCCCC | 16.50 | - | |
| 394 | Sumoylation | NEKPYECKECGKMFS CCCCCCCCCHHCCCC | 44.06 | - | |
| 394 | Sumoylation | NEKPYECKECGKMFS CCCCCCCCCHHCCCC | 44.06 | - | |
| 401 | Phosphorylation | KECGKMFSHGSQLTQ CCHHCCCCCHHHCCC | 24.36 | 29888752 | |
| 404 | Phosphorylation | GKMFSHGSQLTQHQR HCCCCCHHHCCCCCC | 19.32 | 29888752 | |
| 407 | Phosphorylation | FSHGSQLTQHQRIHT CCCHHHCCCCCCCCC | 19.17 | 29888752 | |
| 414 | Phosphorylation | TQHQRIHTGEKPYQC CCCCCCCCCCCCCCC | 44.67 | 29888752 | |
| 422 | Ubiquitination | GEKPYQCKECGKAFN CCCCCCCCCHHHCCC | 40.28 | - | |
| 426 | Acetylation | YQCKECGKAFNRGSL CCCCCHHHCCCCCCC | 62.56 | 30593737 | |
| 432 | Phosphorylation | GKAFNRGSLLTRHQR HHCCCCCCCHHHHCC | 19.57 | 24719451 | |
| 442 | Phosphorylation | TRHQRIHTGEKPYEC HHHCCCCCCCCCCCC | 44.67 | 29496963 | |
| 450 | Sumoylation | GEKPYECKECGKTFS CCCCCCCCCCCCCCC | 44.06 | - | |
| 450 | Sumoylation | GEKPYECKECGKTFS CCCCCCCCCCCCCCC | 44.06 | - | |
| 470 | Phosphorylation | TQHERIHTGEKPYEC CCCCCCCCCCCCCCC | 44.67 | 29496963 | |
| 478 | Sumoylation | GEKPYECKECGKSFI CCCCCCCCCCCCCEE | 44.06 | - | |
| 478 | Sumoylation | GEKPYECKECGKSFI CCCCCCCCCCCCCEE | 44.06 | - | |
| 488 | Phosphorylation | GKSFIRGSQLTQHQR CCCEECCCCCCCCCE | 16.50 | 17525332 | |
| 498 | Phosphorylation | TQHQRIHTGEKPYEC CCCCEECCCCCCCCC | 44.67 | 29496963 | |
| 526 | Phosphorylation | SQHQRLHTGEKPYVC CHHCCCCCCCCCCCC | 52.18 | 21857030 | |
| 529 | Sumoylation | QRLHTGEKPYVCNEC CCCCCCCCCCCCCHH | 42.89 | - | |
| 529 | Sumoylation | QRLHTGEKPYVCNEC CCCCCCCCCCCCCHH | 42.89 | - | |
| 554 | Phosphorylation | IQHQRIHTGEKPYQC EECCCCCCCCCCCCC | 44.67 | 28111955 | |
| 562 | Ubiquitination | GEKPYQCKECGKAFI CCCCCCCCCCCCEEE | 40.28 | - | |
| 566 | Ubiquitination | YQCKECGKAFIRGSQ CCCCCCCCEEECCCC | 52.35 | - | |
| 572 | Phosphorylation | GKAFIRGSQLTQHQR CCEEECCCCCCCCCC | 16.50 | - | |
| 582 | Phosphorylation | TQHQRIHTGEKPYEC CCCCCCCCCCCCCCC | 44.67 | 29496963 | |
| 590 | Sumoylation | GEKPYECKECGKAFS CCCCCCCCCCCCCCC | 44.06 | - | |
| 590 | Sumoylation | GEKPYECKECGKAFS CCCCCCCCCCCCCCC | 44.06 | - | |
| 610 | Phosphorylation | TLHQRIHTGEKPYEC EEEECCCCCCCCCCH | 44.67 | 28111955 | |
| 622 | Sumoylation | YECRECRKAFTQSSH CCHHHHHHHHHCCHH | 60.55 | - | |
| 622 | Sumoylation | YECRECRKAFTQSSH CCHHHHHHHHHCCHH | 60.55 | - | |
| 638 | Phosphorylation | SRHQRIHTGEKPYQC HHHCCCCCCCCCCCC | 44.67 | 28111955 | |
| 646 | Ubiquitination | GEKPYQCKECGKAFT CCCCCCCCCCCCCCC | 40.28 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 68 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN420_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN420_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| P53_HUMAN | TP53 | physical | 19377469 | |
| P53_HUMAN | TP53 | physical | 20713054 | |
| CDN2A_HUMAN | CDKN2A | physical | 20713054 | |
| ARF_HUMAN | CDKN2A | physical | 20713054 | |
| MDM2_HUMAN | MDM2 | physical | 25691462 | |
| CDN2A_HUMAN | CDKN2A | physical | 25691462 | |
| ARF_HUMAN | CDKN2A | physical | 25691462 | |
| UBC9_HUMAN | UBE2I | physical | 25691462 | |
| SENP1_HUMAN | SENP1 | physical | 25691462 | |
| SAV1_HUMAN | SAV1 | physical | 28514442 | |
| STK3_HUMAN | STK3 | physical | 28514442 | |
| H2AX_HUMAN | H2AFX | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY. | |